Neurol India Close
 

Table 2: Patients (and %) with quasi-MMD with AID or MMD in whom neurocognition declined, remained unchanged, or improved after relevant anti-autoimmune treatment

Table 2: Patients (and %) with quasi-MMD with AID or MMD in whom neurocognition declined, remained unchanged, or improved after relevant anti-autoimmune treatment